Fanconi anemia and DNA repair

被引:127
作者
Grompe, M
D'Andrea, A
机构
[1] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Pediat Oncol, Boston, MA 02115 USA
关键词
D O I
10.1093/hmg/10.20.2253
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fanconi anemia (FA) is an autosomal recessive disorder caused by defects in at least eight distinct genes FANCA, B, C, D1, D2, E, F and G. The clinical phenotype of all FA complementation groups is similar and is characterized by progressive bone marrow failure, cancer proneness and typical birth defects. The principal cellular phenotype is hypersensitivity to DNA damage, particularly interstrand DNA crosslinks. The FA proteins constitute a multiprotein pathway whose precise biochemical function(s) remain unknown. Five of the FA proteins (FANCA, C, E, F and G) interact in a nuclear complex upstream of FANCD2. FANCB and FANCD1 have not yet been cloned, but it is likely that FANCB is part of the nuclear complex and that FANCD1 acts downstream of FANCD2. The FA nuclear complex regulates the mono-ubiquitination of FANCD2 in response to DNA damage, resulting in targeting of this protein into nuclear foci. These foci also contain BRCA1 and other DNA damage response proteins. In male meiosis, FANCD2 also co-localizes with BRCA1 at synaptonemal complexes. Together, these data suggest that the FA pathway functions primarily as a DNA damage response system, although its exact role (direct involvement in DNA repair versus indirect, facilitating role) has not yet been defined.
引用
收藏
页码:2253 / 2259
页数:7
相关论文
共 101 条
  • [61] Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C
    Noll, M
    Bateman, RL
    D'Andrea, AD
    Grompe, M
    [J]. MOLECULAR THERAPY, 2001, 3 (01) : 14 - 23
  • [62] NOVOTNA B, 1979, HUM GENET, V49, P41
  • [63] SNX5, a new member of the sorting nexin family, binds to the Fanconi anemia complementation group A protein
    Otsuki, T
    Kajigaya, S
    Ozawa, E
    Liu, JM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (03) : 630 - 635
  • [64] HYPOMUTABILITY IN FANCONI ANEMIA CELLS IS ASSOCIATED WITH INCREASED DELETION FREQUENCY AT THE HPRT LOCUS
    PAPADOPOULO, D
    GUILLOUF, C
    MOHRENWEISER, H
    MOUSTACCHI, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (21) : 8383 - 8387
  • [65] Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner
    Qiao, FY
    Moss, A
    Kupfer, GM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) : 23391 - 23396
  • [66] Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells
    Rathbun, RK
    Faulkner, GR
    Ostroski, MH
    Christianson, TA
    Hughes, G
    Jones, G
    Cahn, R
    Maziarz, R
    Royle, G
    Keeble, W
    Heinrich, MC
    Grompe, M
    Tower, TA
    Bagby, GC
    [J]. BLOOD, 1997, 90 (03) : 974 - 985
  • [67] Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system
    Reuter, T
    Herterich, S
    Bernhard, O
    Hoehn, H
    Gross, HJ
    [J]. BLOOD, 2000, 95 (02) : 719 - 720
  • [68] Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations
    Richardson, C
    Moynahan, ME
    Jasin, M
    [J]. GENES & DEVELOPMENT, 1998, 12 (24) : 3831 - 3842
  • [69] Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity
    Ruffner, H
    Joazeiro, CAP
    Hemmati, D
    Hunter, T
    Verma, IM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (09) : 5134 - 5139
  • [70] EFFECT OF CAFFEINE IN FANCONI ANEMIA .1. RESTORATION OF A NORMAL DURATION OF G2 PHASE
    SABATIER, L
    DUTRILLAUX, B
    [J]. HUMAN GENETICS, 1988, 79 (03) : 242 - 244